Arterial remodelling: an independent pathophysiological component of atherosclerotic disease progression and regression. Insights from serial pharmacological intervention trials.
Schoenhagen
Paul
P
Sipahi
Ilke
I
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D018450:Disease Progression; D006801:Humans; D015337:Multicenter Studies as Topic; D020913:Perindopril / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D020913:Perindopril